---
category: news
title: "ArteraAI Announces First-Ever AI-Derived Biomarker for Predicting Androgen Deprivation Therapy (ADT) Benefit in Prostate Cancer"
excerpt: "ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, announced today the publication of data in"
publishedDateTime: 2023-06-29T20:05:00Z
originalUrl: "https://www.businesswire.com/news/home/20230629089773/en/ArteraAI-Announces-First-Ever-AI-Derived-Biomarker-for-Predicting-Androgen-Deprivation-Therapy-ADT-Benefit-in-Prostate-Cancer/"
webUrl: "https://www.businesswire.com/news/home/20230629089773/en/ArteraAI-Announces-First-Ever-AI-Derived-Biomarker-for-Predicting-Androgen-Deprivation-Therapy-ADT-Benefit-in-Prostate-Cancer/"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "DcbFB/RzB0WhUKDfrjee1NyIA2ehfJbLWNm0VhSw6c4kj/jBCHBHKzgCdR9C6xj4MgtiLe8ZHhXtFjM8ANJfpa2oF5RfNRwk9fr0WGXEounklWT3KkP+QN4nkgLkfm3xZ1jMYnEUncTht7/mCpOsibn2BanjX3c1YAAgX7MB8HsudaX6dRD7DbrTpGlmAKtXmlsOh3Z2XO6CAyBhcNBl1X79Uzzc9Ci07YUuUfUtqfO8hherL45iHXcv/WJ5FnPGwlF5kO/eVchSB/eZEgHTn6xkMNbPxk1oHYICg7Fj0GkgG6937k1LdY/sIZoG39G19SRwfBK1t18Jl6jUD9KL9iMr+gSQ+EU4EaxgoQhyDjw=;T34FnMHUwWRt7gg+mSVYaQ=="
---

